Tech Company Financing Transactions

Ambit Biosciences Funding Round

Ambit Biosciences secured a $31 million Series C funding round on 5/12/2005. Investors included Avalon Ventures, Canadian Medical Discoveries Fund and Forward Ventures.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

11080 Roselle St.
San Diego, CA 92121
USA

Phone

(858) 334-2100

Website

www.ambitbio.com

Email Address

[email protected]

Overview

Ambit Biosciences is a biopharmaceutical company engaged in the discovery and development of small-molecule kinase inhibitors for the treatment of cancer.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Michael Martino

        

Chief Financial Officer

Alan Fuhrman

        

Chief Medical Officer

Athena Countouriotis

        

Browse more venture capital transactions:

Prev: 5/11/2005: Centric Software venture capital transaction
Next: 5/12/2005: Spherics venture capital transaction

Share this article

About Our VC Transactions Data

Our team works diligently to document all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary